John Conley Quoted on Patenting of Human Genes

Robinson Bradshaw’s John M. Conley was quoted in an article on The Verge discussing the practice and implications of patenting human genes. Conley weighed in about how a recent Supreme Court decision could impact scientists’ ability to patent synthetic human genomes created from scratch. He also discussed other external factors that could affect the decisions of which genes are patentable, including whether the gene discovery is novel and how it relates to the genetic field as a whole.

To read “How scientists could patent the genetic blueprint for a human,” please visit The Verge.